After Falling -0.17% During The Past Week, Should You Still Buy Cullinan Therapeutics Inc (NASDAQ: CGEM)?
Cullinan Therapeutics Inc (NASDAQ:CGEM)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting -0.10. At the close of